" class="no-js "lang="en-US"> William Gedale - Medtech Alert
Saturday, September 30, 2023
William Gedale

William Gedale

About William Gedale

William (“Bill”) J. Gedale serves as the Company’s Executive Chairman. Bill is an experienced investor, financial professional and biotech founder. He has been in the investment business since 1965. He is a co-founder and Chairman of Promosome, and Chairman of PIN Pharma. Previously, Mr. Gedale co-founded NGN Capital, a trans-Atlantic life-sciences venture fund, founded Mount Everest Advisors, and served as an investment advisor to individuals and as a full-time consultant to Warburg-Pincus Capital Management, the world’s largest venture capital firm. Before founding Mount Everest Advisors he was a Managing Director at John W. Bristol & Co. and President & Chief Executive Officer of General American Investors. Mr. Gedale has been a director of Board of KIKA Medical Inc. (acquired by Merge Healthcare), BioArray Solutions (acquired by Immucor), Unilab (acquired by Kelso), Allied Clinical Labs (acquired by Labcorp), Bioreliance (acquired by Sigma-Aldrich), U.S. Home Health Care, GAMCO and General American Investors. William Gedale holds an M.B.A. from New York University, a J.D. from Fordham Law School, and an A.B. from Syracuse University.

Related Story

Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-Effective Early-Cancer Detection

July 22 2022

Acuamark Diagnostics (“AcuamarkDx”), an early cancer detection company, today announced the closing of an $11.3 million Series […]